Bloomberg Businessweek cover image

Targeting the Toughest Diseases (Sponsored Content)

Bloomberg Businessweek

Targeting APOL1-Mediated Kidney Disease: Transformative Research and Raising Awareness

6min Snip

00:00
Play full episode
An exploration of Vertex Pharmaceuticals' groundbreaking research on APOL1-mediated kidney disease, including their efforts to develop transformative therapies and raise awareness for the devastating condition.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode